June 10, 2025 - 21:24

Reading, UK: A significant milestone has been reached by a prominent UTM (Unified Traffic Management) technology provider, which has recently been granted a United States patent for its groundbreaking ARROW technology. This innovative system is designed to enhance the management and safety of unmanned aerial vehicles (UAVs) in complex airspace environments.
The ARROW technology stands out for its ability to facilitate seamless communication between drones and air traffic management systems, ensuring that UAV operations can be conducted safely and efficiently. With the growing popularity of drone usage across various sectors, including delivery services, agriculture, and emergency response, the need for advanced traffic management solutions has never been more critical.
This patent not only underscores the company's commitment to innovation but also positions it as a leader in the rapidly evolving drone industry. As regulatory frameworks continue to develop, the ARROW technology is expected to play a pivotal role in shaping the future of drone operations, paving the way for safer skies and more efficient airspace utilization.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...